NCT01091259 2015-11-24Irinotecan and Bevacizumab for Recurrent Ovarian CancerNYU Langone HealthPhase 2 Completed29 enrolled 11 charts
NCT00003345 2013-06-21Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal CancerMemorial Sloan Kettering Cancer CenterPhase 2 Completed35 enrolled